Document:

Form of Restricted Stock Agreement

 EXHIBIT 10.1 
  
 THE TRIZETTO GROUP, INC. 
  
 1998 LONG-TERM INCENTIVE PLAN 
  

  
 Restricted Stock Award Agreement

  

  
 You are hereby awarded Restricted Stock subject to the terms and conditions set forth in this Restricted Stock Award Agreement (“Award”) and in
The TriZetto Group, Inc. 1998 Long-Term Incentive Plan (“Plan”), which is attached hereto as Exhibit A. All terms in this Award that begin with a capital letter are defined in the Plan or in this Award. 
  
 By executing this Award, you agree to be bound by all of the Plan’s
terms and conditions as if they had been set out verbatim in this Award. In addition, you recognize and agree that all determinations, interpretations, or other actions respecting the Plan and this Award will be made by the Plan Administrator, and
shall be final, conclusive and binding on all parties, including you and your successors in interest. 
  
 Specific Terms. Your Restricted Stock has the following terms: 
  

			
		
	 Name of Participant
	  	

		
	 Shares Subject to this Award
	  	             shares of Common Stock of The TriZetto Group, Inc.
		
	 Purchase Price per Share
	  	Not Applicable
		
	 Award Date
	  	                     ,
20        
		
	 Vesting
	  	 You will become vested in              percent
(    %) of the Shares subject to this Award on each of the first          annual anniversary dates of the Award Date, provided that-
 (1)    your Continuous Service has not ended before the particular vesting date; and

(2)
                                        
                                       
 .

		
	 Accelerated Vesting
	  	Your vesting under this Award will accelerate only under the circumstances expressly set forth in the Plan.
		
	 Deferral Election pursuant to Section 9 of the Plan
	  	          You are eligible to make this election if you desire to do so.
          You are not eligible to make this election.

  
 1. Dividends. Upon lapse
of the vesting restrictions on this Award, you will receive an amount equal to any cash dividends (plus simple interest at          percent (        %) per
year), plus a number of Shares equal to any stock dividends, which were declared and paid to the 

 
Company’s shareholders between the Award Date and the date such unrestricted Shares are issued to you. 
  
 2. Investment Purposes. You acknowledge that you are acquiring your Restricted
Stock for investment purposes only and without any present intention of selling or distributing them. 
  
 3. Legend. Until all vesting restrictions lapse and new certificates are issued pursuant to the next section, certificates representing shares of Restricted Stock issued pursuant to this Award shall bear
the following legend: 
  
 The shares represented by this
certificate are subject to reacquisition by, and such shares may not be sold or otherwise transferred except pursuant to, the provisions of the Restricted Stock Award Agreement, dated
                 , 20        , by and between The TriZetto Group, Inc. and the registered owner of such
shares. 
  
 4. Vesting Dates. As you satisfy vesting conditions of
this Award, the Company shall cause new certificates to be issued and delivered to you, free from the legend in the preceding section, but with any other legends the Company determines to be appropriate. New certificates shall not be delivered to
you unless you have made arrangements satisfactory to the Plan Administrator to satisfy tax-withholding obligations. If you do not satisfy the vesting requirements as of any vesting date, you will irrevocably forfeit any rights to those Shares
subject to the vesting requirement on that date. 
  
 5. Section 83(b)
Election Notice. If you elect under Code Section 83(b) to be taxed immediately on your Restricted Stock when it was granted to you, you promise to notify the Company of the election within 10 days of filing that election with the
Internal Revenue Service. Exhibit B is a suggested form of Section 83(b) election. 
  
 6. Deferral Election. If allowed under the Specific Terms, at any time during the calendar year in which you receive this Award, you may irrevocably elect to defer the receipt of all or a percentage of
the Shares that would otherwise be issued to you on the lapsing of vesting restrictions of this Award in a future calendar year (or for the remainder of any calendar year in which you make the election, provided the election occurs within the thirty
(30)-day period after you first became an Eligible Person.) A copy of the form which you may use to make a deferral election is attached hereto as Exhibit C. Notwithstanding the foregoing, Restricted Stock which has been subject to a Section
83(b) election is not eligible for deferral. 
  
 7. Not a Contract of
Employment. By executing this Award, you acknowledge and agree that (1) any person who is terminated before full vesting of an award, such as the one granted to you by this Award, could claim that he or she was terminated to preclude
vesting; (2) you promise never to make such a claim; (3) nothing in this Award or the Plan confers on you any right to continued Company employment or restricts the Company’s right to terminate your employment at any time for any or no reason;
and (4) the Company would not have granted this Award to you but for these acknowledgements and agreements. 
  
 8. Severability. Subject to one exception, every provision of this Award and the Plan is intended to be severable, and any illegal or invalid term shall not affect the validity or legality of the
remaining terms. The only exception is that this Award shall be unenforceable if any provision of the preceding section is illegal, invalid, or unenforceable. 
  

 2 

 9. Notices. Any notice, payment or communication required or permitted to be given by any provision of this
Award shall be in writing and shall be delivered personally or sent by certified mail, return receipt requested, addressed as follows: (i) if to the Company, at the address set forth on the signature page, to the attention of: Plan Administrator of
The TriZetto Group, Inc. 1998 Long-Term Incentive Plan; (ii) if to you, at the address set forth below your signature on the signature page. Each party may, from time to time, by notice to the other party hereto, specify a new address for delivery
of notices relating to this Award. Any such notice shall be deemed to be given as of the date such notice is personally delivered or properly mailed. 
  
 10. Binding Effect. Every provision of this Award shall be binding on and inure to the benefit of the parties’ respective heirs, legatees, legal
representatives, successors, transferees, and assigns. 
  
 11.
Headings. Headings shall be ignored in interpreting this Award. 
  
 12. Counterparts. This Award may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute the
same instrument. 
  
  
 [Signature Page Follows] 
  

 3 

 BY YOUR SIGNATURE BELOW, along with the signature of the Company’s representative, you and the
Company agree that the Award is granted under and governed by the terms and conditions of this Award Agreement and the Plan. 
  
 THE TRIZETTO GROUP, INC. 
  
  
 By:                                      
                                        
       
 Name:                                     
                                
 Title:                                     
                                   
 Address:
                                        
                         
                                       
                           
  

 
 The undersigned Participant hereby accepts the terms of this Award
Agreement and the Plan. 
  
  
 By:                                      
                                        
       
 Name of
Participant:                                      
        
 Address:                                     
                             
                                       
                           
  

 4 

 Exhibit A 
  
 THE TRIZETTO GROUP, INC. 
  
 1998 LONG-TERM INCENTIVE PLAN 

 Exhibit B 
  
 THE TRIZETTO GROUP, INC. 
  
 1998 LONG-TERM INCENTIVE PLAN 
  
 Section 83(b) Election Form 
  
 Attached is an Internal Revenue Code Section 83(b) Election Form. If you wish to make a Section 83(b) election, you must do so within 30 days of the date
the restricted stock was transferred to you. In order to make the election, you must completely fill out the attached form and file one copy with the Internal Revenue Service office where you file your tax return. In addition, one copy of the
statement also must be submitted with your income tax return for the taxable year in which you make this election. Finally, you also must submit a copy of the election form to the Company. A Section 83(b) election normally cannot be revoked.

 THE TRIZETTO GROUP, INC. 
  

 Election to Include Value of Restricted Stock in Gross Income

 in Year of Transfer under Internal Revenue Code Section 83(b) 

  
  
 Pursuant to Section 83(b) of the Internal Revenue Code, I hereby elect within 30 days of receiving the property described herein to be taxed immediately on its value specified in item 5 below. 
  

	1.	My General Information: 

  

			
	 Name:
	  	 
		
	 Address:
	  	 
		
	 	  	 
		
	 SSN/TIN:
	  	 

  

	2.	Description of the property with respect to which I am making this election: 

  

                        
shares of                          stock of The TriZetto Group, Inc. (“Restricted Stock”). 
  

	3.	The Restricted Stock was transferred to me on
                                 , 20    . This
election relates to the 20     calendar taxable year. 

  

	4.	The Restricted Stock is subject to the following restrictions: 

  
 The Restricted Stock is forfeitable until it is earned in accordance with The TriZetto Group, Inc. 1998 Long-term Incentive Plan (the “Plan”),
Restricted Stock Award Agreement (the “Award”) or other Award or Plan provisions. The Restricted Stock generally is not transferable until my interest becomes vested and non-forfeitable, pursuant to the Award and the Plan. 
  

	5.	Fair market value: 

  
 The fair market value at the time of transfer (determined without regard to any restrictions other then restrictions which by their terms never will
lapse) of the Restricted Stock with respect to which I am making this election is $             per share. 
  

	6.	Amount paid for Restricted Stock: 

  
 The amount I paid for the Restricted Stock is $             per share. 

	7.	Furnishing statement to employer: 

  
 A copy of this statement has been furnished to my employer,
                                        .
If the transferor of the Restricted Stock is not my employer, that entity also has been furnished with a copy of this statement. 
  

	8.	Award or Plan not affected: 

  
 Nothing contained herein shall be held to change any of the terms or conditions of the Award or the Plan. 
  
  
 Dated:
                             , 20    . 
  
  
  
                                       
                                        
                                        
                          
 Taxpayer 
  

 Exhibit C 
  
 THE TRIZETTO GROUP, INC. 
  
 1998 LONG-TERM INCENTIVE PLAN 
  
  
 Deferral Election Form 
  
 Attached is the form you may use if you wish to defer the receipt of all or a
percentage of the Shares that would otherwise be issued to you upon the lapse of the vesting restrictions on your Award. You must submit a copy of the Deferral Election Form executed by you to the Company as provided for in the form. An election to
defer receipt of your Shares may not be revoked. 
  
 You are
advised to consult with your individual tax advisor with respect to the tax consequences related to your Award and any elections you may make to defer the receipt of shares. 

 THE TRIZETTO GROUP, INC. 
 1998 LONG-TERM INCENTIVE PLAN 
  

  
 Deferral Election Form 
  

  
  
 Pursuant to Section 6 of the Restricted Share Award granted to me on
            , 20             (the “Award Date”), I hereby irrevocably elect to defer the receipt of
            % of the shares of common stock of the Company that would otherwise be issued to me in a future calendar year upon the lapsing of transfer restrictions of the Award granted to
me under the Plan on the Award Date. All terms that begin with a capital letter are defined in the Plan or in the Award. 
  
 I understand and acknowledge that this election is irrevocable. 
  
 I understand and acknowledge that this election will be ineffective if it is made in a calendar year other than the one in
which the Award Date occurred, unless I have just become an Eligible Person. If I have just become an Eligible Person, I understand that this election will be ineffective with respect to the remainder of this calendar year if my election is made
after the thirtieth day on which I first became an Eligible Person. 
  
  

					
	 Witnessed by:
  
  
  
	 	 	 	PARTICIPANT
	
	 	 	 	

  
 THE TRIZETTO GROUP, INC.

  
 1998 LONG-TERM INCENTIVE PLAN 
  
  
 As Approved by the Board of Directors on March 25, 2004 
  

 THE TRIZETTO GROUP, INC. 
  
 1998 LONG-TERM INCENTIVE PLAN 
  

 
 1.    Amendment and Restatement to the 1998 Stock Option
Plan 
  
 On May 19, 1998, The TriZetto Group, Inc. (the
“Company”) adopted The TriZetto Group, Inc. 1998 Stock Option Plan, which has been amended from time to time prior to 2004 (the “1998 Stock Option Plan”). On March 25, 2004, the Board of the Company further amended and restated
the 1998 Stock Option Plan to read in its entirety as set forth in this 1998 Long-Term Incentive Plan (the “Plan”). Section 20 below summarizes the principal changes made to the 1998 Stock Option Plan pursuant to this amendment and
restatement. 
  
 The Plan permits the granting of the following
types of awards (“Awards”), according to the sections of the Plan listed here: 
  

			
	 Section 6
	  	Options
	 Section 7
	  	Share Appreciation Rights
	 Section 8
	  	Restricted and Unrestricted Share Awards
	 Section 9
	  	Deferred Share Units
	 Section 10
	  	Performance Awards

  
 This amendment and
restatement of the 1998 Stock Option Plan is not intended to affect adversely and shall not affect adversely the rights of any person (in the absence of such person’s consent) under any stock options that the Company or its Affiliates may have
provided pursuant to the 1998 Stock Option Plan before the effective date of this amendment and restatement. In addition, the Plan shall not affect any such compensation or benefits that the Company or its Affiliates may have provided or may
separately provide in the future pursuant to any agreement, plan, or program that is independent of this Plan. 
  
 2.    Defined Terms 
  
 Terms in the Plan that begin with an initial capital letter have the defined meaning set forth in Appendix A, unless defined elsewhere in this Plan or the context of their use clearly indicates a
different meaning. 
  
 3.    Shares Subject to the
Plan 
  
 The maximum number of Shares that the Company
may issue pursuant to all Awards is 13,000,000, including stock options previously granted under the 1998 Stock Option Plan. Subject to this overall limitation on all Awards, the maximum number of Shares that the Company may issue pursuant to Awards
in a form other than Options and SARS is 700,000. The foregoing limitations are subject to adjustment in accordance with Section 13 of the Plan. For all Awards, these Shares may be authorized but unissued Shares, or Shares that the Company has
reacquired or otherwise holds in treasury. 
  
 Shares that are
subject to an Award that for any reason expires, is forfeited, is cancelled, or becomes unexercisable, and Shares that are for any other reason not paid or delivered under the Plan shall again, except to the extent prohibited by Applicable Law, be
available for subsequent Awards under the Plan. In addition, the Committee may make future Awards with respect to Shares that the Company retains from otherwise delivering pursuant to an Award either (i) as payment of the exercise price of an Award,
or (ii) in order to satisfy the withholding or employment taxes due upon the grant, exercise, vesting, or distribution of an Award. Notwithstanding the foregoing, but subject to adjustments pursuant to Section 13 below, the number of Shares that are
available for ISO Awards shall be determined, to the extent required under applicable tax laws, by reducing the number of Shares designated in the preceding paragraph by the number of Shares granted pursuant to Awards (whether or not Shares are
issued 
  

 1 

 pursuant to such Awards); provided that any Shares that are either purchased under the Plan and forfeited back to the
Plan, or surrendered in payment of the Exercise Price for an Award shall be available for issuance pursuant to ISO Awards. 
  
 4.    Administration 
  
 (a) General. The Committee shall administer the Plan in accordance with its terms, provided that the Board may act in lieu of the Committee
on any matter. The Committee shall hold meetings at such times and places as it may determine and make such rules and regulations for the conduct of its business as it deems advisable. In the absence of a duly appointed Committee or if the Board
otherwise chooses to act in lieu of a Committee, the Board shall function as the Committee for all purposes of the Plan. 
  
 (b) Committee Composition. The Board shall appoint the members of the Committee. If and to the extent permitted by Applicable Law, the Committee
may authorize one or more Reporting Persons (or other officers) to make Awards to Eligible Persons who are not Reporting Persons (or other officers who the Committee has specifically authorized to make Awards). The Board may at any time appoint
additional members to the Committee, remove and replace members of the Committee with or without Cause, and fill vacancies on the Committee however caused. 
  
 (c) Powers of the Committee. Subject to the provisions of the Plan, the Committee shall have the authority, in its sole discretion: 
  
 (i) to determine Eligible Persons to whom Awards shall be
granted from time to time and the number of Shares, units, or SARs to be covered by each Award; 
  
 (ii) to determine, from time to time, the Fair Market Value of Shares; 
  
 (iii) to determine, and to set forth in Award Agreements, the terms and conditions of all Awards, including
any applicable exercise or purchase price, the installments and conditions under which an Award shall become vested (which may be based on performance), terminated, expired, cancelled, or replaced, and the circumstances for vesting acceleration or
waiver of forfeiture restrictions, and other restrictions and limitations; 
  
 (iv) to approve the forms of Award Agreements and all other documents, notices and certificates in connection therewith which need not be identical either as to type of Award or among Participants; 
  
 (v) to construe and interpret the terms of the Plan and any
Award Agreement, to determine the meaning of their terms, and to prescribe, amend, and rescind rules and procedures relating to the Plan and its administration; 
  

(vi) in order to fulfill the purposes of the Plan and without amending the Plan, modify, cancel, or waive the Company’s rights
with respect to any Awards, to adjust or to modify Award Agreements for changes in Applicable Law, and to recognize differences in foreign law, tax policies, or customs; and 
  
 (vii) to make all other interpretations and to take all other actions that the Committee may consider
necessary or advisable to administer the Plan or to effectuate its purposes. 
  
 Subject to Applicable Law and the restrictions set forth in the Plan, the Committee may delegate administrative functions to individuals who are Reporting Persons, officers, or Employees of the Company or its
Affiliates. 
  
 (d) Deference to Committee Determinations.
The Committee shall have the discretion to interpret or construe ambiguous, unclear, or implied (but omitted) terms in any fashion it deems to be 
  

 2 

 appropriate in its sole discretion, and to make any findings of fact needed in the administration of the Plan or Award
Agreements. The Committee’s prior exercise of its discretionary authority shall not obligate it to exercise its authority in a like fashion thereafter. The Committee’s interpretation and construction of any provision of the Plan, or of any
Award or Award Agreement, shall be final, binding, and conclusive. The validity of any such interpretation, construction, decision or finding of fact shall not be given de novo review if challenged in court, by arbitration, or in any other forum,
and shall be upheld unless clearly arbitrary or capricious. 
  
 (e) No Liability; Indemnification. Neither the Board nor any Committee member, nor any person acting at the direction of the Board or the Committee, shall be liable for any act, omission, interpretation, construction or determination
made in good faith with respect to the Plan, any Award or any Award Agreement. The Company and its Affiliates shall pay or reimburse any member of the Committee, as well as any Director, Employee, or Consultant who takes action in connection with
the Plan, for all expenses incurred with respect to the Plan, and to the full extent allowable under Applicable Law shall indemnify each and every one of them for any claims, liabilities, and costs (including reasonable attorney’s fees) arising
out of their good faith performance of duties under the Plan. The Company and its Affiliates may obtain liability insurance for this purpose. 
  
 5.    Eligibility 
  
 (a) General Rule. The Committee may grant ISOs only to Employees (including officers who are Employees), and may grant all other Awards to any
Eligible Person. A Participant who has been granted an Award may be granted an additional Award or Awards if the Committee shall so determine, if such person is otherwise an Eligible Person and if otherwise in accordance with the terms of the Plan.

  
 (b) Grant of Awards. Subject to the express provisions
of the Plan, the Committee shall determine from the class of Eligible Persons those individuals to whom Awards under the Plan may be granted, the number of Shares subject to each Award, the price (if any) to be paid for the Shares or the Award and,
in the case of Performance Awards, in addition to the matters addressed in Section 10 below, the specific objectives, goals and performance criteria that further define the Performance Award. Each Award shall be evidenced by an Award Agreement
signed by the Company and, if required by the Committee, by the Participant. The Award Agreement shall set forth the material terms and conditions of the Award established by the Committee. 
  
 (c) Limits on Awards. The maximum number of Shares subject to Awards
that are granted during any calendar year to any one Participant will be limited to 400,000. The Committee will adjust this limitation pursuant to Section 13 below. 
  
 6.    Option Awards 
  
 (a) Types; Documentation. The Committee may in its discretion grant ISOs to any Employee on or before May 19, 2008
(or, if allowable under applicable tax laws, the date ten years after the effective date determined under Section 20 below), and Non-ISOs to any Eligible Person, and shall evidence any such grants in an Award Agreement that is delivered to the
Participant. Each Option shall be designated in the Award Agreement as an ISO or a Non-ISO. At the sole discretion of the Committee, any Option may be exercisable, in whole or in part, immediately upon the grant thereof, or only after the occurrence
of a specified event, or only in installments, which installments may vary. Options granted under the Plan may contain such terms and provisions not inconsistent with the Plan that the Committee shall deem advisable in its sole and absolute
discretion. 
  
 (b) ISO $100,000 Limitation. To the extent
that the aggregate Fair Market Value of Shares with respect to which Options designated as ISOs first become exercisable by a Participant in any calendar year (under this Plan and any other plan of the Company or any Affiliate) exceeds $100,000,
such excess Options shall be treated as Non-ISOs. For purposes of determining whether the $100,000 limit is exceeded, the Fair Market Value of the Shares subject to an ISO shall be determined as of the Grant Date. In reducing the number of Options
treated as ISOs to meet the $100,000 limit, the most 

  

 3 

 recently granted Options shall be reduced first. In the event that Section 422 of the Code is amended to alter the
limitation set forth therein, the limitation of this Section 6(b) shall be automatically adjusted accordingly. 
  
 (c) Term of Options. Each Award Agreement shall specify a term at the end of which the Option automatically expires, subject to earlier termination
provisions contained in Section 6(h) hereof; provided, that, the term of any Option may not exceed ten years from the Grant Date. In the case of an ISO granted to an Employee who is a Ten Percent Holder on the Grant Date, the term of the ISO shall
not exceed five years from the Grant Date. 
  
 (d) Exercise
Price. The exercise price of an Option shall be determined by the Committee in its discretion and shall be set forth in the Award Agreement, subject to the following special rules: 
  
 (i) ISOs. If an ISO is granted to an Employee who on the Grant Date is a Ten Percent Holder, the per
Share exercise price shall not be less than 110% of the Fair Market Value per Share on such Grant Date. If an ISO is granted to any other Employee, the per Share exercise price shall not be less than 100% of the Fair Market Value per Share on the
Grant Date. 
  
 (ii) Non-ISOs. The per
Share exercise price for the Shares to be issued pursuant to the exercise of a Non-ISO shall not be less than 100% of the Fair Market Value per Share on the Grant Date. 
  
 (iii) Named Executive Officers. The per Share exercise price shall not be less than 100% of the Fair
Market Value per Share on the Grant Date of an Option if (A) on such Grant Date, the Participant is subject to the limitations set forth in Section 162(m) of the Code, and (B) the grant is intended to qualify as performance-based compensation under
Section 162(m) of the Code. 
  
 (e) Exercise of Option. The
times, circumstances and conditions under which an Option shall be exercisable shall be determined by the Committee in its sole discretion and set forth in the Award Agreement. The Committee shall have the discretion to determine whether and to what
extent the vesting of Options shall be tolled during any unpaid leave of absence; provided, however, that in the absence of such determination, vesting of Options shall be tolled during any such leave approved by the Company. 
  
 (f) Minimum Exercise Requirements. An Option may not be exercised for
a fraction of a Share. The Committee may require in an Award Agreement that an Option be exercised as to a minimum number of Shares, provided that such requirement shall not prevent a Participant from purchasing the full number of Shares as to which
the Option is then exercisable. 
  
 (g) Methods of
Exercise. Prior to its expiration pursuant to the terms of the applicable Award Agreement, each Option may be exercised, in whole or in part (provided that the Company shall not be required to issue fractional shares), by delivery of
written notice of exercise to the Secretary of the Company accompanied by the full exercise price of the Shares being purchased. In the case of an ISO, the Committee shall determine the acceptable methods of payment on the Grant Date and it shall be
included in the applicable Award Agreement. The methods of payment that the Committee may in its discretion accept or commit to accept in an Award Agreement include: 
  
 (i) cash or check payable to the Company (in U.S. dollars); 
  
 (ii) other Shares that (A) are owned by the Participant who
is purchasing Shares pursuant to an Option, (B) have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which the Option is being exercised, (C) were not acquired by such Participant pursuant to
the exercise of an Option, unless such Shares have been owned by such Participant for at least six months or such other longer period as the Committee may determine, (D) are all, at the time of such surrender, free and clear of any and all 

  

 4 

 
claims, pledges, liens and encumbrances, or any restrictions which would in any manner restrict the transfer of such shares to or by the Company (other than
such restrictions as may have existed prior to an issuance of such Shares by the Company to such Participant), and (E) are duly endorsed for transfer to the Company; 
  
 (iii) a cashless exercise program that the Committee may approve, from time to time in its discretion,
pursuant to which a Participant may concurrently provide irrevocable instructions (A) to such Participant’s broker or dealer to effect the immediate sale of the purchased Shares and remit to the Company, out of the sale proceeds available on
the settlement date, sufficient funds to cover the exercise price of the Option plus all applicable taxes required to be withheld by the Company by reason of such exercise and (B) to the Company to deliver the certificates for the purchased Shares
directly to such broker or dealer in order to complete the sale; or 
  
 (iv) any combination of the foregoing methods of payment. 
  
 The Company shall not be required to deliver Shares pursuant to the exercise of an Option until payment of the full exercise price therefore is received by the Company. 
  
 (h) Termination of Continuous Service. The Committee may establish and
set forth in the applicable Award Agreement the terms and conditions on which an Option shall remain exercisable, if at all, following termination of a Participant’s Continuous Service. The Committee may waive or modify these provisions at any
time. To the extent that a Participant is not entitled to exercise an Option at the date of his or her termination of Continuous Service, or if the Participant (or other person entitled to exercise the Option) does not exercise the Option to the
extent so entitled within the time specified in the Award Agreement or below (as applicable), the Option shall terminate and the Shares underlying the unexercised portion of the Option shall revert to the Plan and become available for future Awards.
In no event may any Option be exercised after the expiration of the Option term as set forth in the Award Agreement. 
  
 The following provisions shall apply to the extent an Award Agreement does not specify the terms and conditions upon which an Option shall terminate when
there is a termination of a Participant’s Continuous Service: 
  
 (i) Termination Other than upon Disability or Death or for Cause. In the event of termination of a Participant’s Continuous Service (other than as a result of Participant’s death, disability,
retirement or termination for Cause), the Participant shall have the right to exercise an Option at any time within 30 days following such termination to the extent the Participant was entitled to exercise such Option at the date of such
termination. 
  
 (ii) Disability, Retirement,
or Death. In the event of termination of a Participant’s Continuous Service as a result of his or her “disability” within the meaning of Section 22(e)(3) of the Code, retirement, or death, the Participant shall have the right to
exercise an Option at any time within one year following such termination to the extent the Participant was entitled to exercise such Option at the date of such termination. 
  
 (iii) Cause. If the Committee determines that a Participant’s Continuous Service terminated due
to Cause, the Participant shall immediately forfeit the right to exercise any Option, and it shall be considered immediately null and void. 
  
 (i) Reverse Vesting. The Committee in its discretion may allow a Participant to exercise unvested Options, in which case the Shares then issued
shall be Restricted Share Units having analogous vesting restrictions to the unvested Options. 
  
 (j) Buyout Provisions. If the Fair Market Value for Shares subject to an Option is more than 33% below their exercise price for more than 30 consecutive business days, the Committee may, pursuant to a program
approved by the Company’s stockholders, unilaterally terminate and cancel the 

  

 5 

 Option either (i) by paying the Participant, in cash or Shares, an amount not less than the Black-Scholes value of the
vested portion of the Option, or (ii) by irrevocably committing to grant a new Option, on a designated date more than six months after such termination and cancellation of such Option (but only if the Participant’s Continuous Service has not
terminated prior to such designated date), on substantially the same terms as the cancelled Option, provided that the per Share exercise price for the new Option shall equal the per Share Fair Market Value of a Share on the date the new grant
occurs. 
  
 7.    Share Appreciation Rights (SARs)

  
 (a) Grants. The Committee may in its discretion
grant Share Appreciation Rights to any Eligible Person, in any of the following forms: 
  
 (i) SARs Related to Options. The Committee may grant SARs either concurrently with the grant of an Option or with respect to an
outstanding Option, in which case the SAR shall extend to all or a portion of the Shares covered by the related Option. An SAR shall entitle the Participant who holds the related Option, upon exercise of the SAR and surrender of the related Option,
or portion thereof, to the extent the SAR and related Option each were previously unexercised, to receive payment of an amount determined pursuant to Section 7(e) below. Any SAR granted in connection with an ISO will contain such terms as may be
required to comply with the provisions of Section 422 of the Code and the regulations promulgated thereunder. 
  
 (ii) SARs Independent of Options. The Committee may grant SARs which are independent of any Option subject to such conditions as
the Committee may in its discretion determine, which conditions will be set forth in the applicable Award Agreement. 
  
 (iii) Limited SARs. The Committee may grant SARs exercisable only upon or in respect of a Change in Control Event or any other
specified event, and such limited SARs may relate to or operate in tandem or combination with or substitution for Options or other SARs, or on a stand-alone basis, and may be payable in cash or Shares based on the spread between the exercise price
of the SAR, and (A) a price based upon or equal to the Fair Market Value of the Shares during a specified period, at a specified time within a specified period before, after or including the date of such event, or (B) a price related to
consideration payable to Company’s stockholders generally in connection with the event. 
  
 (b) Exercise Price. The per Share exercise price of an SAR shall be determined in the sole discretion of the Committee, shall be set forth in the applicable Award Agreement, and shall be no less than 100% of
the Fair Market Value of one Share. The exercise price of an SAR related to an Option shall be the same as the exercise price of the related Option. The exercise price of an SAR shall be subject to the special rules on pricing contained in paragraph
(iii) of Section 6(d) hereof. 
  
 (c) Exercise of SARs.
Unless the Award Agreement otherwise provides, an SAR related to an Option will be exercisable at such time or times, and to the extent, that the related Option will be exercisable. An SAR may not have a term exceeding ten years from its Grant Date.
An SAR granted independently of any other Award will be exercisable pursuant to the terms of the Award Agreement. Whether an SAR is related to an Option or is granted independently, the SAR may only be exercised when the Fair Market Value of the
Shares underlying the SAR exceeds the exercise price of the SAR. 
  
 (d) Effect on Available Shares. To the extent that an SAR is exercised, only the actual number of delivered Shares (if any) will be charged against the maximum number of Shares that may be delivered pursuant to Awards under this
Plan. The number of Shares subject to the SAR and the related Option of the Participant will, however, be reduced by the number of underlying Shares as to which the exercise relates, unless the Award Agreement otherwise provides. 
  
 (e) Payment. Upon exercise of an SAR related to an Option and the
attendant surrender of an exercisable portion of any related Award, the Participant will be entitled to receive payment of an amount determined by multiplying – 
  

 6 

 (i) the excess of the Fair Market Value of a Share on the date of exercise of the SAR
over the exercise price per Share of the SAR, by 
  
 (ii) the number of Shares with respect to which the SAR has been exercised. 
  
 Notwithstanding the foregoing, an SAR granted independently of an Option may limit the amount payable to the Participant to a percentage, specified in the Award Agreement but not exceeding one hundred percent (100%),
of the amount determined pursuant to the preceding sentence. 
  
 (f) Form and Terms of Payment. Subject to Applicable Law, the Committee may, in its sole discretion, settle the amount determined under Section 7(e) above solely in cash, solely in Shares (valued at their Fair Market Value on the
date of exercise of the SAR), or partly in cash and partly in Shares. In any event, cash shall be paid in lieu of fractional Shares. Absent a contrary determination by the Committee, all SARs shall be settled in cash as soon as practicable after
exercise. Notwithstanding the foregoing, the Committee may, in an Award Agreement, determine the maximum amount of cash or Shares or combination thereof that may be delivered upon exercise of an SAR. 
  
 (g) Termination of Employment or Consulting Relationship. The
Committee shall establish and set forth in the applicable Award Agreement the terms and conditions on which an SAR shall remain exercisable, if at all, following termination of a Participant’s Continuous Service. The provisions of Section 6(h)
above shall apply to the extent an Award Agreement does not specify the terms and conditions upon which an SAR shall terminate when there is a termination of a Participant’s Continuous Service. 
  
 (h) Buy-out. The Committee has the same discretion to buy-out SARs as
it has to take such action pursuant to Section 6(j) with respect to Options. 
  
 8.    Restricted and Unrestricted Share Awards 
  
 (a) Grants. The Committee may in its discretion grant restricted shares (“Restricted Shares”) to any Eligible Person and shall evidence such grant in an Award Agreement that is delivered to the
Participant which sets forth the number of Restricted Shares, the purchase price for such Restricted Shares (if any) and the terms upon which the Restricted Shares may become vested. In addition, the Company may in its discretion grant the right to
receive Shares after certain vesting requirements are met (“Restricted Share Units”) to any Eligible Person and shall evidence such grant in an Award Agreement that is delivered to the Participant which sets forth the number of Shares (or
formula, that may be based on future performance or conditions, for determining the number of Shares) that the Participant shall be entitled to receive upon vesting and the terms upon which the Shares subject to a Restricted Share Unit may become
vested. The Committee may condition any Award of Restricted Shares or Restricted Share Units to a Participant on receiving from the Participant such further assurances and documents as the Committee may require to enforce the restrictions. In
addition, the Committee may grant Awards hereunder in the form of unrestricted shares, which shall be called “Unrestricted Shares.” 
  
 (b) Vesting and Forfeiture. The Committee shall set forth in an Award Agreement granting Restricted Shares or Restricted Share Units, the terms and
conditions under which the Participant’s interest in the Restricted Shares or the Shares subject to Restricted Share Units will become vested. Except as set forth in the applicable Award Agreement or the Committee otherwise determines, upon
termination of a Participant’s Continuous Service for any other reason, the Participant shall forfeit his or her Restricted Shares and Restricted Share Units; provided that if a Participant purchases the Restricted Shares and forfeits them for
any reason, the Company shall return the purchase price to the Participant only if and to the extent set forth in an Award Agreement. 
  
 (c) Issuance of Restricted Shares Prior to Vesting. The Company shall issue stock certificates that evidence Restricted Shares pending the lapse of
applicable restrictions, and that bear a legend making appropriate reference to such restrictions. Except as set forth in the applicable Award Agreement or the Committee otherwise determines, the Company or a third party that the Company 

 

 7 

 designates shall hold such Restricted Shares and any dividends that accrue with respect to Restricted Shares pursuant to
Section 8(e) below. 
  
 (d) Issuance of Shares upon
Vesting. As soon as practicable after vesting of a Participant’s Restricted Shares (or Shares underlying Restricted Share Units) and the Participant’s satisfaction of applicable tax withholding requirements, the Company
shall release to the Participant, free from the vesting restrictions, one Share for each vested Restricted Share (or issue one Share free of the vesting restriction for each vested Restricted Share Unit), unless an Award Agreement provides
otherwise. No fractional shares shall be distributed, and cash shall be paid in lieu thereof. 
  
 (e) Dividends Payable on Vesting. Whenever Shares are issued to a Participant or duly-authorized transferee under Section 8(d) above pursuant to the vesting of Restricted Shares or the Shares underlying
Restricted Share Units, such Participant or duly-authorized transferee shall also be entitled to receive, with respect to each Share issued, an amount equal to any cash dividends (plus interest as the Committee may determine) and a number of Shares
equal to any stock dividends, which were declared and paid to the holders of Shares between the Grant Date and the date such Share is issued. 
  
 (f) Section 83(b) Elections. If a Participant who has received Restricted Share Units provides the Committee with written notice of his or her
intention to make an election under Section 83(b) of the Code with respect to the Shares subject to such Restricted Share Units (the “Section 83(b) Election”), the Committee may in its discretion convert the Participant’s Restricted
Share Units into Restricted Shares, on a one-for-one basis, in full satisfaction of the Participant’s Restricted Share Unit Award. 
  
 (g) Deferral Elections. At any time within the calendar year in which a Participant who is a member of a select group of management or highly
compensated employees (within the meaning of the ERISA) receives an Award of either Restricted Shares or Restricted Share Units, the Committee may permit the Participant to irrevocably elect, on a form provided by and acceptable to the Committee, to
defer the receipt of all or a percentage of the Shares that would otherwise be transferred to the Participant upon the vesting of such Award. If the Participant makes this election, the Shares subject to the election, and any associated dividends
and interest, shall be credited to an account established pursuant to Section 9 hereof on the date such Shares would otherwise have been released or issued to the Participant pursuant to Section 8(d) above. Notwithstanding the foregoing, Shares with
respect to which a Participant makes a Section 83(b) Election shall not be eligible for deferral pursuant to Section 9 below. 
  
 9.    Deferred Share Units 
  
 (a) Elections to Defer. The Committee may permit any Eligible Person who is a Director, Consultant or member of a select group of management or
highly compensated employees (within the meaning of the ERISA) to irrevocably elect, on a form provided by and acceptable to the Committee (the “Election Form”), to forego the receipt of cash or other compensation (including Restricted
Shares for which a Section 83(b) Election has not been made, and Shares subject to Restricted Share Units), and in lieu thereof to have the Company credit to an internal Plan account (the “Account”) a number of deferred share units
(“Deferred Share Units”) having a Fair Market Value equal to the Shares and other compensation deferred. These credits will be made at the end of each calendar month during which compensation is deferred. Each Election Form shall take
effect five business days after its delivery to the Company, unless during such five business day period the Company sends the Participant a written notice explaining why the Election Form is invalid. Notwithstanding the foregoing sentence, Election
Forms shall be ineffective with respect to any compensation that a Participant earns before the date on which the Company receives the Election Form. 
  
 (b) Vesting. Each Participant shall be 100% vested at all times in any Shares subject to Deferred Share Units. 
  

 8 

 (c) Issuances of Shares. The Company shall provide a Participant with one Share for each Deferred
Share Unit in five substantially equal annual installments that are issued before the last day of each of the five calendar years that end after the date on which the Participant’s Continuous Service terminates, unless – 

 
 (i) the Participant has properly elected a different form
of distribution, on a form approved by the Committee that permits the Participant to select any combination of a lump sum and annual installments that are completed within ten years following termination of the Participant’s Continuous Service,
and 
  
 (ii) the Company has received the
Participant’s distribution election form either more than 90 days before a Change in Control Event, or more than one year before the date on which the Participant’s Continuous Service terminates for any reason other than death, or before
the Participant’s death. 
  
 Fractional shares shall not be issued, and
instead shall be paid out in cash. 
  
 (d) Crediting of
Dividends. Whenever Shares are issued to a Participant pursuant to Section 9(c) above, such Participant shall also be entitled to receive, with respect to each Share issued, a cash amount equal to any cash dividends (plus interest at a rate as
the Committee may determine), and a number of Shares equal to any stock dividends which were declared and paid to the holders of Shares between the Grant Date and the date such Share is issued. 
  
 (e) Hardship Withdrawals. In the event a Participant suffers an
unforeseeable hardship within the contemplation of this Section 9(e), the Participant may apply to the Company for an immediate distribution of all or a portion of the Participant’s Deferred Share Units. The hardship must result from a sudden
and unexpected illness or accident of the Participant or a dependent of the Participant, casualty loss of property, or other similar conditions beyond the control of the Participant. Examples of purposes that are not considered hardships include
post-secondary school expenses or the desire to purchase a residence. In no event will a distribution be made to the extent the hardship could be relieved through reimbursement or compensation by insurance or otherwise, or by liquidation of the
Participant’s nonessential assets to the extent such liquidation would not itself cause a severe financial hardship. The amount of any distribution hereunder shall be limited to the amount necessary to relieve the Participant’s financial
hardship. The Committee shall determine whether a Participant has a qualifying hardship and the amount which qualifies for distribution, if any. The Committee may require evidence of the purpose and amount of the need, and may establish such
application or other procedures as it deems appropriate. 
  
 (f)
Unsecured Rights to Deferred Compensation. A Participant’s right to Deferred Share Units shall at all times constitute an unsecured promise of the Company to pay benefits as they come due. The right of the Participant or the
Participant’s duly-authorized transferee to receive benefits hereunder shall be solely an unsecured claim against the general assets of the Company. Neither the Participant nor the Participant’s duly-authorized transferee shall have any
claim against or rights in any specific assets, shares, or other funds of the Company. 
  
 10.    Performance Awards 
  
 (a) Performance Units. The Committee may in its discretion grant Performance Units to any Eligible Person and shall evidence such grant in an Award Agreement that is delivered to the Participant which sets forth the terms and
conditions of the Award. A Performance Unit is an Award which is based on the achievement of specific goals with respect to the Company or any Affiliate or individual performance of the Participant, or a combination thereof, over a specified period
of time. The maximum Performance Unit compensation that may be paid to any one Participant with respect to any one Performance Period (hereinafter defined) shall be 500,000 Shares and $2,000,000 in cash. 
  
 (b) Performance Compensation Awards. The Committee may, at the time of
grant of a Performance Unit, designate such Award as a “Performance Compensation Award” in order that such 
  

 9 

 Award constitutes “qualified performance-based compensation” under Code Section 162(m), in which event the
Committee shall have the power to grant such Performance Compensation Award upon terms and conditions that qualify it as “qualified performance-based compensation” within the meaning of Code Section 162(m). With respect to each such
Performance Compensation Award, the Committee shall establish, in writing within the time required under Code Section 162(m), a “Performance Period,” “Performance Measure(s),” and “Performance Formula(e)” (each such
term being hereinafter defined). Once established for a Performance Period, the Performance Measure(s) and Performance Formula(e) shall not be amended or otherwise modified to the extent such amendment or modification would cause the compensation
payable pursuant to the Award to fail to constitute qualified performance-based compensation under Code Section 162(m). 
  
 A Participant shall be eligible to receive payment in respect of a Performance Compensation Award only to the extent that the Performance Measure(s) for
such Award are achieved and the Performance Formula(e) as applied against such Performance Measure(s) determines that all or some portion of such Participant’s Award has been earned for the Performance Period. As soon as practicable after the
close of each Performance Period, the Committee shall review and certify in writing whether, and to what extent, the Performance Measure(s) for the Performance Period have been achieved and, if so, determine and certify in writing the amount of the
Performance Compensation Award to be paid to the Participant and, in so doing, may use negative discretion to decrease, but not increase, the amount of the Award otherwise payable to the Participant based upon such performance. 
  
 (c) Definitions. 
  
 (i) Performance Formula” means, for a Performance
Period, one or more objective formulas or standards established by the Committee for purposes of determining whether or the extent to which an Award has been earned based on the level of performance attained or to be attained with respect to one or
more Performance Measure(s). Performance Formula may vary from Performance Period to Performance Period and from Participant to Participant and may be established on a stand-alone basis, in tandem or in the alternative. 
  
 (ii) Performance Measure” means one or more of the
following selected by the Committee to measure Company, Affiliate, and/or business unit performance for a Performance Period, whether in absolute or relative terms (including, without limitation, terms relative to a peer group or index): basic,
diluted, or adjusted earnings per share; sales or revenue; earnings before interest, taxes, and other adjustments (in total or on a per share basis); basic or adjusted net income; returns on equity, assets, capital, revenue or similar measure;
economic value added; working capital; total shareholder return; and product development, product market share, research, licensing, litigation, human resources, information services, mergers, acquisitions, sales of assets of Affiliates or business
units. Each such measure shall be, to the extent applicable, determined in accordance with generally accepted accounting principles as consistently applied by the Company (or such other standard applied by the Committee) and, if so determined by the
Committee, and in the case of a Performance Compensation Award, to the extent permitted under Code Section 162(m), adjusted to omit the effects of extraordinary items, gain or loss on the disposal of a business segment, unusual or infrequently
occurring events and transactions and cumulative effects of changes in accounting principles. Performance Measures may vary from Performance Period to Performance Period and from Participant to Participant, and may be established on a stand-alone
basis, in tandem or in the alternative. 
  
 (iii)
Performance Period” means one or more periods of time (of not less than one fiscal year of the Company), as the Committee may designate, over which the attainment of one or more Performance Measure(s) will be measured for the purpose of
determining a Participant’s rights in respect of an Award. 
  

 10 

 11.    Taxes 
  
 (a) General. As a condition to the issuance or distribution of Shares pursuant to the Plan, the Participant (or in
the case of the Participant’s death, the person who succeeds to the Participant’s rights) shall make such arrangements as the Company may require for the satisfaction of any applicable federal, state, local or foreign withholding tax
obligations that may arise in connection with the Award and the issuance of Shares. The Company shall not be required to issue any Shares until such obligations are satisfied. If the Committee allows the withholding or surrender of Shares to satisfy
a Participant’s tax withholding obligations, the Committee shall not allow Shares to be withheld in an amount that exceeds the minimum statutory withholding rates for federal and state tax purposes, including payroll taxes. 
  
 (b) Default Rule for Employees. In the absence of any other
arrangement, an Employee shall be deemed to have directed the Company to withhold or collect from his or her cash compensation an amount sufficient to satisfy such tax obligations from the next payroll payment otherwise payable after the date of the
exercise of an Award. 
  
 (c) Special Rules. In the case of
a Participant other than an Employee (or in the case of an Employee where the next payroll payment is not sufficient to satisfy such tax obligations, with respect to any remaining tax obligations), in the absence of any other arrangement and to the
extent permitted under the Applicable Law, the Participant shall be deemed to have elected to have the Company withhold from the Shares or cash to be issued pursuant to an Award that number of Shares having a Fair Market Value determined as of the
applicable Tax Date (as defined below) equal to the amount required to be withheld. For purposes of this Section 11, the Fair Market Value of the Shares to be withheld shall be determined on the date that the amount of tax to be withheld is to be
determined under the Applicable Law (the “Tax Date”). 
  
 (d) Surrender of Shares. If permitted by the Committee, in its discretion, a Participant may satisfy the minimum applicable tax withholding and employment tax obligations associated with an Award by surrendering Shares to the Company
(including Shares that would otherwise be issued pursuant to the Award) that have a Fair Market Value determined as of the applicable Tax Date equal to the amount required to be withheld. In the case of Shares previously acquired from the Company
that are surrendered under this Section 11, such Shares must have been owned by the Participant for more than six months on the date of surrender (or such longer period of time the Company may in its discretion require). 
  
 12.    Non-Transferability of Awards 
  
 (a) General. Except as set forth in this Section 12, or as otherwise
approved by the Committee for a select group of management or highly compensated Employees, Awards may not be sold, pledged, assigned, hypothecated, transferred or disposed of in any manner other than by will or by the laws of descent or
distribution. The designation of a beneficiary by a Participant will not constitute a transfer. An Award may be exercised, during the lifetime of the holder of an Award, only by such holder, the duly-authorized legal representative of a disabled
Participant, or a transferee permitted by this Section 12. 
  
 (b)
Limited Transferability Rights. Notwithstanding anything else in this Section 12, the Committee may in its discretion provide in an Award Agreement that the Award may be transferred by instrument to an inter vivos or testamentary trust
(or other entity) in which the Award is to be passed to beneficiaries upon the death of the trustor (settlor), or by gift to charitable institutions, the Participant’s “Immediate Family” (as defined below), on such terms and
conditions as the Committee deems appropriate. “Immediate Family” means any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law,
daughter-in-law, brother-in-law, or sister-in-law, and shall include adoptive relationships. 
  

 11 

 13.    Adjustments upon Changes in Capitalization, Merger or Certain Other Transactions

  
 (a) Changes in Capitalization. The Committee may
equitably adjust the number of Shares covered by each outstanding Award, and the number of Shares that have been authorized for issuance under the Plan but as to which no Awards have yet been granted or that have been returned to the Plan upon
cancellation, forfeiture, or expiration of an Award, as well as the price per Share covered by each such outstanding Award, to reflect any increase or decrease in the number of issued Shares resulting from a stock-split, reverse stock-split, stock
dividend, combination, recapitalization or reclassification of the Shares, or any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company. In the event of any such transaction or event, the
Committee may provide in substitution for any or all outstanding Options under the Plan such alternative consideration (including securities of any surviving entity) as it may in good faith determine to be equitable under the circumstances and may
require in connection therewith the surrender of all Options so replaced. In any case, such substitution of securities shall not require the consent of any person who is granted Options pursuant to the Plan. Except as expressly provided herein, no
issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be required to be made with respect to, the number or price of Shares
subject to any Award. 
  
 (b) Acceleration of Awards Upon
Change in Control Event. Unless prior to a Change in Control Event, the Committee determines that, upon its occurrence, benefits under any or all Awards will not accelerate (or the Committee determines that only certain or limited benefits under
any or all Awards will be accelerated and the extent to which they will be accelerated) and/or establishes a different time in respect of such Change in Control Event for such acceleration, then, immediately upon the occurrence of a Change in
Control Event, the vesting of all Awards shall be accelerated so that Awards shall vest (and, to the extent applicable, become exercisable) as to the Shares that otherwise would have been unvested and the repurchase rights of the Company with
respect to Shares issued upon exercise of Awards shall lapse as to the Shares subject to such repurchase rights. The Committee may override the limitations on acceleration in this Section 13(b) by express provision in the Award Agreement and may
accord any Eligible Person a right to refuse any acceleration, whether pursuant to the Award Agreement or otherwise, in such circumstances as the Committee may approve. Any acceleration of Awards will comply with Applicable Law. 
  
 (c) Possible Early Termination of Accelerated Awards. If the vesting
of any Award under the Plan has been fully accelerated as a result of any Change in Control Event that has been approved by the Board, but such Award is not exercised by the Participant before the event giving rise to such Change in Control Event is
consummated, than such Award will terminate, subject to any provision that has been expressly made by the Committee through a plan of reorganization approved by the Board for the survival, substitution, assumption, exchange or other settlement of
such Award. 
  
 (d) Golden Parachute Limitations. Unless
otherwise specified in an Award Agreement, no Award will be accelerated under the Plan to an extent or in a manner that would not be fully deductible by the Company for federal income tax purposes because of Section 280G of the Code, nor will any
payment hereunder be accelerated if any portion of such accelerated payment would not be deductible by the Company because of Section 280G of the Code. If a Participant would be entitled to benefits or payments hereunder and under any other plan or
program that would constitute “parachute payments” as defined in Section 280G of the Code, then the Participant may by written notice to the Company designate the order in which such parachute payments will be reduced or modified so that
the Company is not denied federal income tax deductions for any “parachute payments” because of Section 280G of the Code. 
  
 (e) Certain Distributions. In the event of any distribution to the Company’s stockholders of securities of any other entity or other assets
(other than dividends payable in cash or stock of the Company) without receipt of consideration by the Company, the Committee may, in its discretion, appropriately adjust the price per Share covered by each outstanding Award to reflect the effect of
such distribution. 
  

 12 

 14.    Time of Granting Awards 
  
 The date of grant (“Grant Date”) of an Award shall be the date on
which the Committee makes the determination granting such Award or such other date as is determined by the Committee, provided that in the case of an ISO, the Grant Date shall be the later of the date on which the Committee makes the determination
granting such ISO or the date of commencement of the Participant’s employment relationship with the Company. 
  
 15.    Modification of Awards and Substitution of Options 
  
 (a) Modification, Extension, and Renewal of Awards. Within the limitations of the Plan and any Award Agreement, the
Committee may modify an Award, to accelerate the rate at which an Option or SAR may be exercised (including without limitation permitting an Option or SAR to be exercised in full without regard to the installment or vesting provisions of the
applicable Award Agreement or whether the Option or SAR is at the time exercisable, to the extent it has not previously been exercised), to accelerate the vesting of any Award, to extend or renew outstanding Awards, or, subject to the restrictions
set forth in Sections 6(j) and 7(h), to accept the cancellation of outstanding Awards to the extent not previously exercised either for the granting of new Awards or for other consideration in substitution or replacement thereof. 
  
 (b) Substitution of Options. Notwithstanding any inconsistent
provisions or limits under the Plan, in the event the Company or an Affiliate acquires (whether by purchase, merger or otherwise) all or substantially all of outstanding capital stock or assets of another corporation or in the event of any
reorganization or other transaction qualifying under Section 424 of the Code, the Committee may, in accordance with the provisions of that Section, substitute Options for options under the plan of the acquired company provided (i) the excess of the
aggregate fair market value of the shares subject to an option immediately after the substitution over the aggregate option price of such shares is not more than the similar excess immediately before such substitution and (ii) the new Option does
not give persons additional benefits, including any extension of the exercise period. 
  
 16.    Term of Plan 
  
 The Plan shall continue in effect for a term of ten (10) years from its effective date as determined under Section 20 below, unless the Plan is sooner terminated under Section 17 below. 
  
 17.    Amendment and Termination of the Plan 
  
 (a) Authority to Amend or Terminate. Subject to Applicable Laws, the
Board may from time to time amend, alter, suspend, discontinue, or terminate the Plan. 
  
 (b) Effect of Amendment or Termination. No amendment, suspension, or termination of the Plan shall materially and adversely affect Awards already granted unless either it relates to an adjustment pursuant to
Section 13 above, or it is otherwise mutually agreed between the Participant and the Committee, which agreement must be in writing and signed by the Participant and the Company. Notwithstanding the foregoing, the Committee may amend the Plan to
eliminate provisions which are no longer necessary as a result of changes in tax or securities laws or regulations, or in the interpretation thereof. 
  
 18.    Conditions upon Issuance of Shares 
  
 Notwithstanding any other provision of the Plan or any agreement entered into by the Company pursuant to the Plan, the Company shall not be obligated, and
shall have no liability for failure, to issue or deliver any Shares under the Plan unless such issuance or delivery would comply with the Applicable Law, with such compliance determined by the Company in consultation with its legal counsel.

  

 13 

 19.    Reservation of Shares 
  
 The Company, during the term of this Plan, will at all times reserve and keep
available such number of Shares as shall be sufficient to satisfy the requirements of the Plan. 
  
 20.    Effective Date 
  
 This amendment and restatement to the 1998 Stock Option Plan made pursuant to this Plan shall become effective on March 25, 2004, provided that this Plan shall be submitted to the Company’s stockholders for
approval at the Company’s 2004 Annual Meeting of Stockholders, and if not approved by the stockholders at such meeting, this amendment and restatement, and any Awards granted under the Plan other than Options, shall be null, void, and of no
force and effect, and the Company’s 1998 Stock Option Plan shall continue in effect in accordance with its terms that were in effect immediately before the Board approved this amendment and restatement. Awards other than Options that are
granted under this Plan before approval of this Plan by the stockholders shall be granted subject to such approval and no Shares shall be distributed before such approval is obtained. The principal changes made to the 1998 Stock Option Plan pursuant
to this amendment and restatement are as follows: (i) renaming it “The TriZetto Group, Inc. 1998 Long-Term Incentive Plan,” (ii) increasing the number of Shares available for issuance by 2,000,000 (from 11,000,000 to 13,000,000 Shares),
(iii) adding provisions that permit Awards other than Options and (iv) modifying the Committee’s discretion to administer the Plan and past or future Awards. 
  
 The terms and conditions of all Options outstanding under the 1998 Stock Option Plan immediately before the effective date
of this amendment and restatement shall continue to be governed by the terms and conditions of the 1998 Stock Option Plan (and the respective instruments evidencing each such option) as in effect on the date each such option was granted; provided,
however, that any one or more provisions of the amended and restated Plan, may, in the Committee’s discretion, be extended to one or more of such Options (subject to the Participant’s written consent of any adverse changes). 
  
 21.    Controlling Law 
  
 All disputes relating to or arising from the Plan shall be governed by the
internal substantive laws (and not the laws of conflicts of laws) of the State of Delaware, to the extent not preempted by United States federal law. If any provision of this Plan is held by a court of competent jurisdiction to be invalid and
unenforceable, the remaining provisions shall continue to be fully effective. 
  
 22.    Laws and Regulations. 
  
 (a) U.S. Securities Laws. This Plan, the grant of Awards, and the exercise of Options and SARs under this Plan, and the obligation of the Company to sell or deliver any of its securities (including, without limitation, Options,
Restricted Shares, Restricted Share Units, Deferred Share Units, and Shares) under this Plan shall be subject to all Applicable Law. In the event that the Shares are not registered under the Securities Act of 1933, as amended (the “Act”),
or any applicable state securities laws prior to the delivery of such Shares, the Company may require, as a condition to the issuance thereof, that the persons to whom Shares are to be issued represent and warrant in writing to the Company that such
Shares are being acquired by him or her for investment for his or her own account and not with a view to, for resale in connection with, or with an intent of participating directly or indirectly in, any distribution of such Shares within the meaning
of the Act, and a legend to that effect may be placed on the certificates representing the Shares. 
  
 (b) Other Jurisdictions. To facilitate the making of any grant of an Award under this Plan, the Committee may provide for such special terms for
Awards to Participants who are foreign nationals or who are employed by the Company or any Affiliate outside of the United States of America as the Committee may consider necessary or appropriate to accommodate differences in local law, tax policy
or custom. The Company may adopt rules and procedures relating to the operation and administration of this Plan to accommodate the specific requirements of local laws and procedures of particular countries. 
  

 14 

 Without limiting the foregoing, the Company is specifically authorized to adopt rules and procedures regarding the
conversion of local currency, taxes, withholding procedures and handling of stock certificates which vary with the customs and requirements of particular countries. The Company may adopt sub-plans applicable to particular locations and countries.

  
 23.    No Shareholder Rights 
  
 Neither a Participant nor any transferee of a Participant shall have any
rights as a shareholder of the Company with respect to any Shares underlying any Award until the date of issuance of a share certificate to a Participant or a transferee of a Participant for such Shares in accordance with the Company’s
governing instruments and Applicable Law. Prior to the issuance of Shares pursuant to an Award, a Participant shall not have the right to vote or to receive dividends or any other rights as a shareholder with respect to the Shares underlying the
Award, notwithstanding its exercise in the case of Options and SARs. No adjustment will be made for a dividend or other right that is determined based on a record date prior to the date the stock certificate is issued, except as otherwise
specifically provided for in this Plan. 
  
 24.    No
Employment Rights 
  
 The Plan shall not confer upon any
Participant any right to continue an employment, service or consulting relationship with the Company, nor shall it affect in any way a Participant’s right or the Company’s right to terminate the Participant’s employment, service, or
consulting relationship at any time, with or without Cause. 
  

 15 

 THE TRIZETTO GROUP, INC. 
  
 1998 LONG-TERM INCENTIVE PLAN 
  

Appendix A: Definitions 
  
  
 As used in the Plan, the following definitions shall apply: 
  
 “Affiliate” means any entity, including any “parent
corporation” or “subsidiary corporation” within the meaning of Section 424 of the Code, which together with the Company is under common control within the meaning of Section 414 of the Code. 
  
 “Applicable Law” means the legal requirements relating to the
administration of options and share-based plans under applicable U.S. federal and state laws, the Code, any applicable stock exchange or automated quotation system rules or regulations, and the applicable laws of any other country or jurisdiction
where Awards are granted, as such laws, rules, regulations and requirements shall be in place from time to time. 
  
 “Award” means any award made pursuant to the Plan, including awards made in the form of an Option, an SAR, a Restricted Share, a Restricted Share
Unit, an Unrestricted Share, a Deferred Share Unit and a Performance Award, or any combination thereof, whether alternative or cumulative, authorized by and granted under this Plan. 
  
 “Award Agreement” means any written document setting forth the terms of an Award that has been authorized by the
Committee. The Committee shall determine the form or forms of documents to be used, and may change them from time to time for any reason. 
  
 “Board” means the Board of Directors of the Company. 
  
 “Cause” for termination of a Participant’s Continuous Service will exist if the Participant is terminated from employment or other service
with the Company or an Affiliate for any of the following reasons: 
  
 (i) the Participant’s willful failure substantially to perform his or her duties and responsibilities to the Company or deliberate violation of a material Company policy; 
  
 (ii) the Participant’s commission of any material act or acts of fraud, embezzlement, dishonesty or other willful
misconduct; 
  
 (iii) the Participant’s material unauthorized
use or disclosure of any proprietary information or trade secrets of the Company or any other party to whom the Participant owes an obligation of nondisclosure as a result of his or her relationship with the Company; or 
  
 (iv) Participant’s willful and material breach of any of his or her
obligations under any written agreement or covenant with the Company. 
  
 The
Committee shall, in its discretion, determine whether or not a Participant is being terminated for Cause. The Committee’s determination shall, unless arbitrary and capricious, be final and binding on the Participant, the Company, and all other
affected persons. The foregoing definition does not in any way limit the Company’s ability to terminate a Participant’s employment or consulting relationship at any time, and the term “Company” will be interpreted herein to
include any Affiliate or successor thereto, if appropriate. 
  

 16 

 “Change in Control Event” means any of the following: 
  
 (i) Approval by the stockholders of the Company of the dissolution or
liquidation of the Company; 
  
 (ii) Approval by the stockholders
of the Company of an agreement to merge or consolidate, or otherwise reorganize, with or into one or more entities that are not Affiliates, as a result of which less than 50% of the outstanding voting securities of the surviving or resulting entity
immediately after the reorganization are, or will be, owned, directly or indirectly, by stockholders of the Company immediately before such reorganization (assuming for purposes of such determination that there is no change in the record ownership
of the Company’s securities from the record date for such approval until such reorganization and that such record owners hold no securities of the other parties to such reorganization), but including in such determination any securities of the
other parties to such reorganization held by affiliates of the Company); 
  
 (iii) Approval by the stockholders of the Company of the sale of substantially all of the Company’s business and/or assets to a person or entity that is not an Affiliate; 
  
 (iv) Any “person” (as such term is used in Sections 13(d) and 14(d)
of the Exchange Act but excluding any person described in and satisfying the conditions of Rule 13d-1(b)(1) thereunder), other than a person that was a stockholder of the Company on May 19, 1998 becomes the beneficial owner (as defined in Rule 13d-3
under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company’s then outstanding securities entitled to then vote generally in the election of directors of
the Company; or 
  
 (v) During any period not longer than two
consecutive years, individuals who at the beginning of such period constituted the Board cease to constitute at least a majority thereof, unless the election, or the nomination for election by the Company’s stockholders, of each new Board
member was approved by a vote of at least three-fourths of the Board members then still in office who were Board members at the beginning of such period (including for these purposes, new members whose election or nomination was so approved).

  
 “Code” means the U.S. Internal Revenue Code of 1986,
as amended. 
  
 “Committee” means one or more committees
or subcommittees of the Board appointed by the Board to administer the Plan in accordance with Section 4 above. With respect to any decision involving an Award intended to satisfy the requirements of Section 162(m) of the Code, the Committee shall
consist of two or more Directors of the Company who are “outside directors” within the meaning of Section 162(m) of the Code. 
  
 “Company” means The TriZetto Group, Inc., a Delaware corporation. 
  
 “Consultant” means any person, including an advisor, who is engaged by the Company or any Affiliate to render
services and is compensated for such services. 
  
 “Continuous
Service” means the absence of any interruption or termination of service as an Employee, Director, or Consultant. Continuous Service shall not be considered interrupted in the case of: (i) sick leave; (ii) military leave; (iii) any
other leave of absence approved by the Committee, provided that such leave is for a period of not more than 90 days, unless reemployment upon the expiration of such leave is guaranteed by contract or statute, or unless provided otherwise pursuant to
Company policy adopted from time to time; (iv) changes in status from Director to advisory director or emeritus status; or (v) in the case of transfers between locations of the Company or between the Company, its Affiliates or their respective
successors. Changes in status between service as an Employee, Director, and a Consultant will not constitute an interruption of Continuous Service. 
  

 17 

 “Deferred Share Units” mean Awards pursuant to Section 9 of the Plan. 
  
 “Director” means a member of the Board, or a member of the board of
directors of an Affiliate. 
  
 “Eligible Person” means any
Consultant, Director or Employee and includes non-Employees to whom an offer of employment has been extended. 
  
 “Employee” means any person who the Company or any Affiliate classifies as an employee (including an officer) for employment tax purposes. The payment by the Company of a director’s fee to
a Director shall not be sufficient to constitute “employment” of such Director by the Company. 
  
 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
  
 “Fair Market Value” means, as of any date (the “Determination Date”): (i) the closing price of a Share on the New York Stock Exchange or
the American Stock Exchange (collectively, the “Exchange”), on the Determination Date, or, if shares were not traded on the Determination Date, then on the nearest preceding trading day during which a sale occurred; or (ii) if such stock
is not traded on the Exchange but is quoted on NASDAQ or a successor quotation system, (A) the last sales price (if the stock is then listed as a National Market Issue under The Nasdaq National Market System) or (B) the mean between the closing
representative bid and asked prices (in all other cases) for the stock on the Determination Date as reported by NASDAQ or such successor quotation system; or (iii) if such stock is not traded on the Exchange or quoted on NASDAQ but is otherwise
traded in the over-the-counter, the mean between the representative bid and asked prices on the Determination Date; or (iv) if subsections (i)-(iii) do not apply, the fair market value established in good faith by the Board. 
  
 “Grant Date” has the meaning set forth in Section 14 of the Plan.

  
 “Incentive Share Option or ISO” hereinafter means an
Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code, as designated in the applicable Award Agreement. 
  
 “Non-ISO” means an Option not intended to qualify as an ISO, as designated in the applicable Award Agreement. 
  
 “Option” means any stock option granted pursuant to Section 6 of the
Plan. 
  
 “Participant” means any holder of one or more
Awards, or the Shares issuable or issued upon exercise of such Awards, under the Plan. 
  
 “Performance Awards” mean Performance Units and Performance Compensation Awards granted pursuant to Section 10. 
  
 “Performance Compensation Awards” mean Awards granted pursuant to Section 10(b) of the Plan. 
  
 “Performance Unit” means Awards granted pursuant to Section 10(a) of
the Plan which may be paid in cash, in Shares, or such combination of cash and Shares as the Committee in its sole discretion shall determine. 
  
 “Plan” means The TriZetto Group, Inc. 1998 Long-Term Incentive Plan, as amended and restated hereby. 
  
 “Reporting Person” means an officer, Director, or greater than ten
percent shareholder of the Company within the meaning of Rule 16a-2 under the Exchange Act, who is required to file reports pursuant to Rule 16a-3 under the Exchange Act. 
  
 “Restricted Shares” mean Shares subject to restrictions imposed pursuant to Section 8 of the Plan. 
  

 18 

 “Restricted Share Units” mean Awards pursuant to Section 8 of the Plan. 
  
 “Rule 16b-3” means Rule 16b-3 promulgated under the Exchange Act, as
amended from time to time, or any successor provision. 
  
 “SAR”
or “Share Appreciation Right” means Awards granted pursuant to Section 7 of the Plan. 
  
 “Share” means an ordinary voting share of the Company, as adjusted in accordance with Section 13 of the Plan. 
  
 “Ten Percent Holder” means a person who owns stock representing more than ten percent (10%) of the combined voting
power of all classes of stock of the Company or any Affiliate. 
  
 “Unrestricted Shares” means Awards granted without restrictions pursuant to Section 8 of the Plan. 
  

 19Transition Agreement

					
	 	  	 	  	 [ ] = Confidential Treatment Requested Under
 17 C.F.R. §§ 200.80(b)(4) and 240.24b-2; Text
 Omitted and Filed Separately with the Securities
 and Exchange Commission

  
 Exhibit 10.49

  
 Zymetrics Transition Agreement 
  
 THIS AGREEMENT (the “Transition Agreement”) dated as of May 28,
2004 is made by and among Diversa Corporation (“Diversa”), a Delaware corporation, Zymetrics, Inc., a Delaware corporation (“Zymetrics” and successor to Novartis Enzymes, Inc.), Syngenta Seeds AG (“Syngenta Seeds” and
successor to Novartis Seeds AG), a Swiss corporation, and Syngenta Participations AG (“Syngenta”), a Swiss corporation (individually a “Party” and collectively the “Parties”). 
  
 WHEREAS Diversa and Zymetrics are parties to the Research and Development
Agreement dated and effective as of December 1, 1999 (the “Zymetrics Agreement”), and Diversa and Syngenta Seeds are parties to the Joint Venture Agreement dated and effective as of December 1, 1999 (the “Joint Venture
Agreement”); 
  
 WHEREAS the Joint Venture Agreement and the
Zymetrics Agreement will each terminate on November 30, 2004; 
  
 WHEREAS Diversa and Syngenta are parties to the Amended and Restated Research Collaboration Agreement entered into as of January 3, 2003 (the “Research Collaboration Agreement”); 
  
 WHEREAS Diversa and Syngenta Seeds desire to amend the Joint Venture
Agreement and whereas Diversa and Zymetrics desire to amend the Zymetrics Agreement to provide for the transition of certain rights and obligations under the Joint Venture Agreement and the Zymetrics Agreement to the Research Collaboration
Agreement, as amended, on the terms and conditions set forth herein; and 
  
 WHEREAS Diversa and Syngenta desire to amend the Research Collaboration Agreement accordingly under the terms and conditions of an Amendment entered into contemporaneously with this Transition Agreement (the
“Amendment”). 
  
 NOW THEREFORE, in consideration of the
mutual covenants set forth in this Transition Agreement, the Parties hereby agree to amend the Joint Venture Agreement and the Zymetrics Agreement as follows: 
  

 1. 

	 	1.	Definitions 

  
 The definitions set forth in the Joint Venture Agreement and the Zymetrics Agreement are amended or expanded as follows: 
  
 1.1 “CDB” has the meaning set forth under the term “Commercial Development Biomolecule” in the Joint Venture Agreement. 
  
 1.2 “Effective Date” means February 21, 2004. 
  
 1.3 “[...***...] TB Set” means the set of TBs designated by the
Zymetrics Research Committee associated with the [...***...] project that are included within the Pre-Amendment Inventions. 
  
 1.4 “Post-Amendment Inventions” means all TBs, CDBs, and Biomolecules invented under the Zymetrics Agreement which are not “Pre-Amendment Inventions.”

  
 1.5 “Pre-Amendment Inventions” means the TBs, CDBs and all
Biomolecules invented and precisely described but not yet tested under the criteria set forth in the project plans to establish TB or CDB status under the Zymetrics Agreement as of the Effective Date, as documented by written records under the
project plans, which have been described in the list delivered by Diversa to Syngenta as of the date of execution of this Transition Agreement. 
  
 1.6 “[...***...] TB Set” means the set of TBs designated by the Zymetrics Research Committee associated with the [...***...] project
that are included within the Pre-Amendment Inventions resulting in the product referred to as “[...***...].” 
  
 1.7 “TB” has the meaning set forth under the term “Transferred Biomolecule” in the Zymetrics Agreement. 
  
 1.8 “TB Sets” mean the [...***...] TB Set, [...***...] TB
Set, [...***...] TB Set, [...***...] TB Set, and [...***...] TB Set which are each listed separately in the list referenced in Section 1.5 hereof and as to which Diversa has delivered to Syngenta as of the date
of execution of this Transition Agreement respective gene sequences and other information to uniquely identify each TB in each set. 
  
 1.9 “[...***...] TB Set” means the set of TBs designated by the Zymetrics Research Committee associated with the [...***...] project
that are included within the Pre-Amendment Inventions. 
  

					
	 	 	2.	  	 [ ] = Confidential Treatment Requested;
 Text Filed
Separately with the Securities
 and Exchange Commission

 1.10 “[...***...] TB Set” means the set of TBs designated by the Zymetrics Research Committee
associated with the [...***...] project that are included within the Pre-Amendment Inventions. 
  
 1.11 “[...***...] TB Set” means the set of TBs designated by the Zymetrics Research Committee associated with the [...***...] project that are included within the Pre-Amendment
Inventions. 
  

	 	2.	Transition to Research and Collaboration Agreement 

  
 2.1 As of the Effective Date, Syngenta Seeds and Zymetrics agree to transfer their respective rights and obligations under the Zymetrics Agreement and the Joint Venture
Agreement with respect to the Post-Amendment Inventions and the Pre-Amendment Inventions, and all related data, information, reports, records, and intellectual property rights to Syngenta, and Syngenta agrees to accept such rights and obligations as
set forth in the Amendment under the terms of the Research Collaboration Agreement, as amended by the Amendment. 
  
 2.2 As of the Effective Date, Diversa agrees that its rights and obligations with respect to the Post-Amendment Inventions and the Pre-Amendment Inventions, and all
related data, information, reports, records and intellectual property rights, shall be governed by the terms of the Research Collaboration Agreement, as amended by the Amendment. 
  
 2.3 As of the Effective Date, there shall be no further research funding under the Joint Venture Agreement and the Zymetrics Agreement, and
all funding of Diversa research and development activities by Syngenta or any of its Affiliates shall be governed by the terms and conditions of the Research Collaboration Agreement, as amended by the Amendment. 
  
 2.4 As of the Effective Date, all rights and obligations with respect to commercialization
fees, profit sharing and royalties, or any other payments specified in the Joint Venture Agreement or the Zymetrics Agreement shall be governed and superseded by the Research Collaboration Agreement, as amended by the Amendment. The third to last
sentence of Section 10.4 of the Zymetrics Agreement is hereby deleted and replaced with the following: “The financial obligations of each Party with respect to Transferred Biomolecules or Commercial Development Biomolecules under this
Agreement, any License executed pursuant to Section 4.1, or the Joint Venture Agreement shall survive termination or expiration of this Agreement and be 

  

					
	 	 	3.	  	 [ ] = Confidential Treatment Requested;
 Text Filed
Separately with the Securities
 and Exchange Commission

 
governed by the terms of the Amended and Restated Research Collaboration Agreement between Syngenta Participations AG and Diversa dated as of January 3,
2003, as amended.” 
  
 2.5 As of the Effective Date, Section 2.1 of the Joint
Venture Agreement is amended such that, to the extent Diversa has the right to do so, Diversa agrees to make available to Syngenta and its Affiliates those rights and technology which are necessary for Syngenta and its Affiliates to commercialize
the Zymetrics Microbial Products and the Zymetrics Transgenic Products (as defined in the Amendment). 
  
 2.6 This Transition Agreement is in full satisfaction of Diversa’s and Syngenta Seeds’ obligations under the last sentence of Section 9.1 of the Joint Venture Agreement. 
  

	 	3.	Board of Directors and Operational Management of Zymetrics 

  
 3.1 Articles 4 and 5 of the Joint Venture Agreement are deleted in their entirety. The management, operation, and control of Zymetrics and its management shall be in the
sole discretion of Syngenta Seeds and its Affiliates. All Diversa nominees to the Board of Directors of Zymetrics shall tender their written resignation effective as of the date of this Transition Agreement. The number of employees or consultants
retained by Zymetrics shall be determined by Zymetrics in its sole discretion. Diversa shall have no obligation to pay for any Management Expenses, as defined in the Joint Venture Agreement, incurred on or after the date of this Transition
Agreement. Sections 6.1.2 and 6.1.3 of the Joint Venture Agreement are amended accordingly. 
  

	 	4.	Research Advisory Committee; Dispute Resolution Process 

  
 4.1 Section 3 of the Zymetrics Agreement shall be deleted in its entirety. As of the Effective Date, the Research Committee under the Research Collaboration Agreement
shall also have the responsibility for the research and development program for the Pre-Amendment Inventions and the Post-Amendment Inventions, in accordance with the terms of the Research Collaboration Agreement, as amended by the Amendment.

  
 4.2 The dispute resolution process, including the arbitration provisions, of
the Research Collaboration Agreement shall govern any dispute arising out of the Zymetrics Agreement or the Joint Venture Agreement. Section 11.3 of the Zymetrics Agreement is deleted. 
  

 4. 

	 	5.	Non-Compete Agreement 

  
 5.1 For good and valuable consideration, effective July 16, 2002, Diversa agrees not to market or commercialize, directly or indirectly, or grant a license to any Third
Party to market or commercialize any TBs, or products containing or consisting of TBs, within (a) the [...***...] TB Set, (b) the [...***...] TB Set, (c) the [...***...] TB Set, (d) the [...***...]
TB Set and/or (e) the [...***...] TB Set, which TBs or products containing or consisting of TBs [...***...] (the “[...***...]”). 
  
 5.2. The obligations set forth in Section 5.1 with respect to TBs within the [...***...] TB Set, [...***...] TB
Set, [...***...] TB Set, [...***...] TB Set, and/or [...***...] TB Set, as applicable, shall continue on a TB Set-by-TB Set basis so long as either Syngenta Seeds, Syngenta or any of either of their Affiliates
is funding research and/or development activity (internally or externally) or is manufacturing, selling, marketing or otherwise commercializing [...***...]. Diversa’s obligation of non-competition shall survive termination of the
Zymetrics Agreement, the Joint Venture Agreement and the Research Collaboration Agreement. 
  
 5.3 Syngenta’s and its Affiliates’ rights and Diversa’s non-competition obligations as set forth in this Transition Agreement are in addition to, and not in derogation of, any rights that they have
under the Research Collaboration Agreement, as amended by the Amendment. 
  

	 	6.	Termination 

  
 6.1 The Joint Venture Agreement and the Zymetrics Agreement will terminate as of November 30, 2004. 
  
 6.2 Section 9.4 of the Joint Venture Agreement is amended and restated in its entirety as follows: 
  
 “9.4 Termination or expiration of this Agreement shall not relieve the parties or any obligation accruing prior to such termination or
expiration, nor shall it encumber any of the rights accrued to a Party hereunder prior to such termination or expiration. In addition, upon termination or expiration of this Agreement, the rights granted to the Parties under Sections 2.1, 2.2 and
2.3 for 

  

					
	 	 	5.	  	 [ ] = Confidential Treatment Requested;
 Text Filed
Separately with the Securities
 and Exchange Commission

 
Diversa Technology shall survive as they relate to Pre-Amendment Inventions, and Post-Amendment Inventions. Further, Diversa will not assert against
Syngenta, its Affiliates or Sublicensees any right to patents or know-how it may develop or acquire after the Research Period with respect to such Pre-Amendment Inventions and Post-Amendment Inventions, and further provided that the financial
obligations of each party with respect to Pre-Amendment Inventions and Post-Amendment Inventions under the provisions of Section 6.4, 6.5, 6.6 and 6.10, as amended, are terminated as of the Effective Date of the Transition Agreement between Diversa,
Zymetrics, Syngenta Seeds AG, and Syngenta Participation AG and are superseded by the Amendment to the Amended and Research Collaboration Agreement between Diversa and Syngenta Participations AG of even date herewith. Further, the provisions of
Sections 7.1, 7.2, 7.3, 7.4, 8.2, 8.3, 9.3. 9.4, and 10 of the Joint Venture Agreement and the provisions of the Transition Agreement shall survive the expiration or termination of this Agreement. Termination of this Agreement pursuant to Section
9.2 shall not limit any other rights and remedies of the terminating party.” 
  
 6.3 For avoidance of doubt, certain of the definitions in the Zymetrics Agreement and the Joint Venture Agreement shall survive termination of such agreements to the extent used and referenced in the Amendment.

  
 IN WITNESS WHEREOF, the Parties have caused this Transition Agreement to be
executed by their duly authorized representatives. 
  

									
	 Diversa Corporation
	 	 	 	 Zymetrics, Inc.

					
	By:	 	 /s/ William Baum
	 	 	 	By:	 	 /s/ Edward C. Lesle

	 	 	 William Baum – EVP
	 	 	 	 	 	 Secretary

  

									
	 Syngenta Seeds AG
	 	 	 	 Syngenta Participations AG

					
	By:	 	 /s/ Adrian Dubock
	 	 	 	By:	 	 /s/ Adrian Dubock

	 	 	 Adrian Dubock
 Head M&A Ventures
	 	 	 	 	 	 Adrian Dubock
 Head M&A Ventures

					
	By:	 	 /s/ Marian T. Flattery
	 	 	 	By:	 	 /s/ Marian T. Flattery

	 	 	 Marian T. Flattery
 Head of IP and Licensing
	 	 	 	 	 	 Marian T. Flattery
 Head of IP and Licensing

  

 6.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}]]